Our objective was to investigate the mechanisms by which the endogenous CRHR2 in white adipose tissue (WAT) regulates metabolic activities associated with lipogenesis and lipolysis under continuous exposure to hypoxia. We found that hypobaric hypoxia at a simulated altitude of 5000 m significantly reduced the body weight, food intake, and WAT mass of rats. Hypoxia also accelerated lipolysis and suppressed lipogenesis in WAT. Pretreatment with astressin 2B, a selective CRHR2 antagonist, partly but significantly attenuated the hypoxia-induced reductions in body weight and WAT mass by blocking the cAMP-protein kinase A (PKA)-hormone-sensitive lipase (HSL)/perilipin signalling pathway. Astressin 2B treatment failed to attenuate hypoxia induced lipogenic inhibition. In conclusion, activation of endogenous WAT Ucn2/3 autocrine/paracrine pathway was involved in hypoxia induced lipolysis via CRHR2 -cAMP-PKA signalling pathway. This study provides the novel understanding of local CRHR2 signaling pathway playing important role in WAT loss and lipid metabolism under hypoxia.
Introduction
People who ascend to high altitude for recreational activities, such as climbing, trekking, or skiing, or for work, often experience weight loss during their stay at high altitude (Benso et al., 2007; Rose et al., 1988) . Accumulated evidence suggests that high altitude (HA) hypoxia-induced weight loss is predominantly due to a decrease in fat mass (Armellini et al., 1997; Boyer and Blume, 1984) . White adipose tissue (WAT) was considered as the largest reservoir of fuel and played a crucial role in the regulation of whole-body energy homeostasis. Therefore, elucidating the cellular and molecular mechanisms that underlie the reduction in fat mass during hypoxic conditions is of great importance in preventing fat mass and maintaining energy homeostasis WAT is a major endocrine organ that produces several hormones, known as adipokines, which influence thermogenic activities, food intake, and glucose homeostasis (Rosen and Spiegelman, 2006; Trayhurn and Wood, 2004) . It is also well established that adipose tissue is sensitive to the circulating oxygen concentration. Exposure to hypoxia and a reduction in PaO 2 may disturb WAT activity and induce metabolism (Famulla et al., 2012; Trayhurn et al., 2008; Wang et al., 2008) . Hashimoto et al. (2013) Abbreviations: CRHR2, corticotrophin-releasing hormone receptor type 2; Ucn2, urocortin 2; Ucn3, urocortin 3; WAT, white adipose tissue; BAT, brown adipose tissue; PKA, protein kinase A; PDE3B, phosphodiesterase 3B; ATGL, adipose triglyceride lipase; HSL, hormone sensitive lipase; peri, perilipin; PPAR-a, peroxisome proliferator-activated receptor-a; CPT-1, carnitine palmitoyltransferase-1; ACO, acyl-CoA oxidase; ACC1, acetyl CoA carboxylase 1; PPAR-c, peroxisome proliferator-activated receptor-c; SREBP-1c, sterol regulatory element-binding protein 1c; FAS, fatty acid synthase; SCD-1, stearoyl CoA desaturase; UCP-1, uncoupling protein-1; FFA, free fatty acid; TG, triglyceride. and the expression of lipogenic protein, and increases basal lipolysis in differentiated 3T3-L1 adipocytes. In a mouse model of chronic hypoxia, both AT mass and adipocyte size markedly reduced. Concomitantly, chronic hypoxia also induced significant alterations in AT metabolic gene expression and inflammation profile (van den Borst et al., 2013) . In addition, training under hypoxia resulted in a greater reduction in body fat mass compared to exercise under normoxia (Wiesner et al., 2010) .
The corticotropin-releasing hormone (CRH) family was composed of receptors encoded by two different genes (CRHR1 and CRHR2) and several related peptides (CRH, urocortin, urocortin 2, and urocortin 3). Both Ucn2 (Reyes et al., 2001 ) and Ucn3 ) selectively bind to corticotropin-releasing hormone receptor 2 (CRHR2) but weakly bind to CRHR1, which were considered as endogenous ligands for CRFR2. Extensive evidence showed that CRHR2 played critical role in the central homeostatic mechanisms that control food intake and energy balance (Bakshi et al., 2007; Chen et al., 2012; Yakabi et al., 2011) .
Recently, more and more researchers began to focus on the biological effects of local CRH family in peripheral tissues and organs. It was found that CRH receptors and peptides were highly expressed in the skin tissue (Rassouli et al., 2011) , skeletal muscle tissue and adrenal gland (Tsatsanis et al., 2007) . Further studies suggested that endogenous CRH family were involved in the regulation of physiological functions and metabolism via autocrine/ paracrine manner. For instance, Chen et al. (2006) found that Ucn 2 functioned as a local negative regulator of glucose uptake in skeletal muscle, which might provide benefits in insulin-resistant states such as type 2 diabetes. More recently, endogenous cardiac Ucn2/CRHR2 was found to mitigate against ischemia/reperfusion injury in autocrine/paracrine manner by activating AMPK signaling pathway (Li et al., 2013) .
Although our knowledge of the functional roles of the CRH system in maintenance of energy homeostasis and metabolic pathways is increasing rapidly, little is known regarding the putative role of local CRH system in WAT. Whether local CRHR2 might play similar roles in WAT is not known, we therefore decided to test the hypothesis that endogenous WAT CRHR2 autocrine/paracrine pathway may also directly modulate the hypoxia induced lipid metabolism on the basis of the following: (1) WAT is sensitive to oxygen concentration and hypoxia could induce obvious alteration in lipid metabolism; (2) CRH receptors and its ligands were also expressed in WAT, with the most abundant receptor being CRHR2 (Seres et al., 2004) ; (3) CRHR2 agonists may protect muscle from excessive intracellular lipid storage and thus from lipotoxicityinduced insulin resistance (Solinas et al., 2006) ; (4) CRHR2 in the ventromedial nucleus of hypothalamus (VMH) could regulate peripheral lipid lipolysis metabolism in WAT (Chao et al., 2012) ; (5) Ucn3 transgenic mice (Ucn3 + ) exhibit lean body composition and protection against high fat diet-induced obesity and fat deposits (Jamieson et al., 2011) .
To address this issue, we investigated the effects of CRHR2 in hypoxia-induced fat loss using a CRHR2 antagonist, astressin 2B. The main objective of this study was to clarify the mechanism by which the CRHR2 signalling pathway regulates peripheral adipose tissue metabolism under continuous exposure to hypoxic conditions, equivalent to an altitude of 5000 m.
Materials and methods

Animals
Adult male Sprague Dawley rats (150-200 g) were purchased from Weitong lihua Laboratory Animal Limited Company and Laboratory Animal Center of Zhejiang Province, China (Certification No. SCXK2008-0033). The rats were housed at room temperature (20-22°C) and in a 12-12 h light-dark cycle with free access to food and water and adapted to the condition above for 1 week before experiment. All experiments were conducted in strict accordance with the laboratory animal care guidelines published by the US National Institutes of Health (NIH publication No. 85-23, revised 1996) . All protocols concerning animal use were approved by the Institutional Animal Care and Use Committee of Institute of Basic Medical Sciences, Peking Union Medical College and School of Medicine, Zhejiang University.
Hypoxic challenge
Hypoxia group rats were placed in a hypobaric chamber (Guizhou Fenglei Air Ordnance Co., Ltd.) and subjected to hypoxia mimicking an altitude of 5000 m (54.02 kPa, 10.8% O 2 ) for 1, 2, 5, and 10 d. The chamber was opened daily for 30 min to clean and replenish food and water. Body weights and food intake were monitored daily. All the rats were sacrificed by decapitation and Plasma was obtained by centrifugation and stored at À80°C. The perirenal fat pads were collected and weighed immediately, frozen in liquid nitrogen, and stored at À80°C. Brown adipose tissue (BAT) were isolated and and stored at À80°C.
CRHR2 antagonist treatment
The CRHR2 antagonist astressin 2B was commercially purchased (Sigma-Aldrich) and rats were given at 30 lg/kg body weight. Astressin 2B was double-distilled water (pH 7.0) by intra-peritoneal injection before hypoxic challenge.
Histology, staining, and immunostaining
WAT was fixed in 4% paraformaldehyde overnight and stained with hematoxylin and eosin. The WAT cell volumes were analyzed as described previously (Gerin et al., 2005) . For immunostaining, sections were deparaffinized and rehydrated in xylene and ethanol. WAT sections were incubated in PBS containing 3% H 2 O 2 for 15 min to block endogenous peroxidase activity, and then soaked immersed in a sodium citrate solution for antigen retrieval using pressure cooking method. After blocking with 5% normal bovine serum, the sections were incubated overnight at 4°C with the primary antibodies CRHR2 (Abcam). After rinsing with PBS, the sections were incubated with the biotinylated secondary antibody, rabbit anti-rabbit IgG (Zhongshan, Beijing, China), at room temperature for 30 min. The streptavidin-peroxidase activity was visualized with diaminobenzidine method. Negative controls were incubated with preimmune serum instead of primary antibodies.
Reverse-transcription PCR and quantitative real-time PCR
Total RNA was prepared from frozen tissues with TRIZOL (Invitrogen) reagent and the cDNA was synthesized using TransScript TM First-Strand cDNA Synthesis Super-Mix (TransGenBiotech, AT301). The program was run on a S1000 Thermal Cycler. Quantitative real-time PCR was performed using the SYBR Ò Pre-mix Ex TaqTMkit (Takara, RR420A) and analyzed in a step-one plus RT-PCR system (Life Science, Applied Biosystems). The primer sequences are listed in Supp. 1.
Western blotting and densitometry analyses
Homogenized rat WAT were lysed in 200 ll RIPA lysis buffer (Beyotime, P0013B) with 1% phenylmethyl sulfonylfluoride and 4% complete protease inhibitor cocktail mix (Roche, Mannheim, Germany). Extracts were centrifuged at 14,000g for 15 min at 4°C. Eighty micrograms of total protein was used for sodium dodecyl sulphate-polyacrylamide gel electrophoresis, followed by transferring blotting to nitrocellulose membrane (Millipore Corp., Billerica, MA, USA). Membranes were then blocked with 5% non-fat dried milk in PBS for 1 h with gentle shaking. Membranes were incubated first with (anti-FAS, anti-p-HSL, anti-HSL antibody (Bioworld Scientific), anti-PPAR-a, anti-pPKA antibodies, anti-Phospho-PKA Substrate (RRXS * /T * ) (Cell Signaling Technology), anti-CRHR2, anti-b-actin antibody (Abcam), anti-HIF-1a (Novus), anti-SREBP1c, anti-PDE3B, anti-ATGL, anti-perilipin and anti-UCP-1 antibodies (Santa Cruz Biotechnology) were incubated overnight at 4°C, in 1% BSA in PBS overnight at 4°C with shaking, washed and incubated with secondary antibodies for 2 h at room temperature. Finally, the samples were visualized by enhanced chemi-luminescence. After scanning, band density was analyzed using Image J 1.33 software (National Institutes of Health, Bethesda, MD, USA)
Plasma measurements
Plasma levels of triglyceride (TG) and total cholesterol were assayed according to the manufacturer's recommendations using a commercial enzymatic kit supplied by Zhejiang Dongou Biotechnology. Non-esterified fatty acid (NEFA) and glycerol were measured using NEFA kit (Jiancheng Biotechnology, Nanjing, China) and Glycerol Assay kit (Jiancheng Biotechnology, Nanjing, China), respectively. All of these assays were performed according to manufacturer's instructions.
Statistical analysis
The data are presented as mean ± standard error (SE). For realtime PCR, the relative expression level of each gene was calculated by DD CT. Results are shown as fold-changes from the control group. For Western blot, protein levels were normalised to b-actin. Statistical analysis was performed with SPSS 18.0 software using the two-tailed, unpaired Student's t-test. Multiple groups were compared by one-way analysis of variance (ANOVA) followed by the least significant difference (LSD) test.
Results
3.1. Continuous exposure to hypoxia, equivalent to an altitude of 5000 m, markedly reduced body weight and food intake of rats Consistent with a previous report (Chen et al., 2007) , exposure to hypoxia equivalent to an altitude of 5000 m for 1-10 d significantly reduced the body weight of rats relative to that of rats maintained in normoxic conditions (equivalent to sea level). The reduction body weight was greatest on Day 1 of the study.
Although the body weight of rats exposed to hypoxia gradually increased thereafter, it was consistently and significantly lower in the hypoxic group than in the normoxic group throughout the trial. Exposure to hypoxia initially induced significant weight loss and decreased food intake, but after 5 d, food intake gradually normalised, whereas body weight remained at low levels compared with control group (Fig. 1A and B) . These data suggest that a new homeostatic equilibrium was established, which is characterised by a hypermetabolic state.
3.2. Continuous exposure to hypoxia, equivalent to an altitude of 5000 m, significantly reduced fat mass and adipocyte volume
The hypoxic rats also displayed significant reduced perirenal fat loss compared with the normoxic rats on days 5 and 10 of the trial ( Fig. 2A) . In support of this finding, histological analysis of WAT showed that continuous hypoxia significantly reduced the volume of adipocytes by 24-64% compared with that in normoxic rats from Day 2 to 10 ( Fig. 2B and C) .
Continuous hypoxia accelerated free fatty acid release
TG store in adipocyte constitute the primary energy reserves in rodent. The lipolytic reaction in adipocyte governs the lipolysis of triglyceride and the release of fatty acids that are transported in the plasma to supply energy requirement of various tissues. Free fatty acid (FFA) was considered as an indicator for lipolysis. We found that plasma FFA significantly increased at hypoxia for 1 d and 2 d compared with normoxic rats (Fig. 3A) . Exposure to hypoxia increased glycerol (Fig. 3B) level and decreased the plasma total cholesterol (Fig. 3C ) in hypoxic rats for 1, 2, 5, or 10 d. Plasma levels of triglyceride significantly increased in the acute hypoxia exposure period (day 1). Then plasma triglyceride levels significantly decreased compared with control groups at day 5 and 10 ( Fig. 3D) .
Continuous hypoxia accelerated triglyceride lipolysis and the expression of b-oxidation-related genes in WAT
An imbalance in triglyceride synthesis, lipolysis, and fatty acid b-oxidation might contribute to the reduction in WAT mass in hypoxic rats. To investigate whether the smaller adipocyte volume in hypoxic rats was due to increased lipolysis and/or fatty acid b-oxidation, we examined the changes in the levels of genes involved in these processes in WAT. Although the total hormone-sensitive lipase (HSL) and perilipin expression levels were not significantly different among the study groups, the levels of pPKA, phosphorylated (p)-HSL and p-Perilipin were significantly greater in the hypoxic groups from Days 1 to 10 than in the hypoxic groups ( Fig. 4A  and 4B) . Thus, the p-HSL/HSL ratio (Fig. 4C ) and p-Perilipin/Perilipin (Fig. 4D) were significantly greater in the hypoxic group. Perilipin is the most abundant protein on the surfaces of adipocyte lipid droplets (LD), and the major substrate for cAMP-PKA in lipolytically stimulated adipocytes (Sztalryd et al., 2003) . After the activation of PKA, perilipin effectively promote the translation of HSL from cytoplasm to the surface of LD, which facilitates maximal lipolysis by HSL and ATGL (Brasaemle, 2007) . Consistent with increased levels of p-HSL, the WAT levels of phosphorylated protein kinase A (PKA), which phosphorylates HSL and perilipin (Miyoshi et al., 2006; Sztalryd et al., 2003) , were also significantly increased in hypoxic rats (Fig. 4B ). These data indicated that hypoxia exposure stimulated lipolysis through cAMP-PKA signaling pathway. Phosphodiesterases (PDE) are a superfamily of enzymes degrading adenosine monophosphate (cAMP) and cyclic guanosine monophoshpate (cGMP). PDE3B is highly expressed in WAT and is involved in the regulation of insulin-induced glucose uptake and lipogenesis (Zmuda-Trzebiatowska et al., 2006) . However, we did not observe significant changes in expression levels of PDE3B in this study (Fig. 4E) . No significant changes in protein expression levels of ATGL were observed during hypoxia exposure either (Fig. 4F) . To examine whether genes related to fatty acid b-oxidation in WAT were also affected by hypoxia, we examined the mRNA expression levels of genes encoding the transcription factor peroxisome proliferator-activated receptor (PPAR)-a and its target genes carnitine palmitoyltransferase-1 (CPT-1) and acyl-CoA oxidase (ACO). Intriguingly, all of these genes were upregulated by hypoxia (Fig.4G-I) .
The major role of BAT is thermogenesis and energy expenditure, which is mediated by upregulation of uncoupling protein-1 (UCP-1) (Kozak et al., 2010) . We also determined the levels of UCP-1 in BAT. As shown in Fig. 4J , hypoxia significantly increased the protein expression of UCP-1 in BAT. The increased expression of PPAR-a mRNA in the hypoxic group was accompanied by a significant increase in PPAR-a protein expression compared with the normoxic group (Fig. 4G and K) .
Continuous hypoxia suppressed lipogenesis in WAT
Impaired lipogenesis may also contributed to adipocyte shrinking induced by continuous hypoxia. Therefore, we determined the mRNA expression levels of several genes involved in triglyceride synthesis, namely acetyl CoA carboxylase 1 (ACC1), fatty acid synthase (FAS), and stearoyl CoA desaturase (SCD)-1. An earlier study showed that hypoxic conditions significantly decreased FAS activity in differentiated 3T3-L1 adipocytes (Hashimoto et al., 2013) . In line with this, we found that the mRNA and protein expression levels of FAS in WAT were significantly reduced in hypoxic rats compared with normoxic rats (Fig. 5A and B) , and the mRNA of SCD-1 and ACC-1 was decreased in hypoxic rat (Fig. 5A) . Additionally, the levels of sterol regulatory element-binding protein 1c (SREBP-1c) , the major transcription factor that regulates lipogenesis in WAT, were also markedly decreased by continuous exposure to hypoxia for 1-10 d (Fig. 5C ). PPAR-c is a nuclear hormone receptor that controls adipocyte differentiation (White and Stephens, 2010) and it also considered as one of the most important lipogenic factor in WAT (Siersbaek et al., 2012) . We found that the protein levels of PPAR-c in WAT were significantly reduced in hypoxic rats compared with normoxic rats (Fig. 5D) 3.6. Involvement of the CRHR2-cAMP-PKA signalling pathway in the regulation of lipogenic gene expression
To explore the role of CRHR2 in hypoxia induced lipid metabolism, we first examined the cellular distribution of CRHR2 protein by immunohistochemistry and found that CRHR2 was confined to the cytoplasmic rim and the cell membrane of adipocytes (Fig. 6A) . The mRNA expression levels of CRHR2, Ucn2 and Ucn3 were examined by real-time quantitative PCR (Fig. 6B-D) . Continuous exposure to hypoxia for 1 day significantly increased the mRNA levels of CRHR2 and Ucn2. mRNA levels of Ucn3 were significantly greater in the hypoxic groups from day 1 to 10 than in the hypoxic groups. Additionally, the mRNA levels of CRHR2 were significantly increased by hypoxia for 2 days. Consistent with the results of RT-PCR and immunohistochemistry, hypoxia also increased the protein expression levels of CRHR2 and Ucn2 in WAT ( Fig. 6E and  F) . Protein expression levels of hypoxia inducible factor-1a (HIF1a) in WAT also significantly increased under hypoxia (Fig. 6G) . Because Ucn2/3 and CRHR2 were highly expressed in WAT and CRHR2 could couple to and activate Gs-proteins and stimulate cAMP-PKA signalling pathway (Grammatopoulos 2012) . We hypothesised that endogenous CRHR2 might activate the cAMP-PKA in an autocrine/paracrine manner during hypoxia. Thus, we pretreated rats with astressin 2B, a selective CRHR2 antagonist, before exposing rats to hypoxia to determine the contribution of the CRHR2 signalling pathway to WAT loss and the associated changes in gene expression. Treatment with astressin 2B partially but significantly attenuated the reductions in body weight and WAT mass at Day 1 and 5 of exposure to hypoxia (Fig. 7A and C) , and attenuated hypoxia-induced decrease in food intake (Fig. 7B) . Pretreatment with astressin 2B also attenuated hypoxia-induced upregulation of the cAMP-PKA-HSL/perilipin signalling pathway (Fig. 7D-G) . However, astressin 2B treatment failed to attenuate hypoxia-induced decrease in expression levels of PPAR-c (Fig. 7H) . Taken together, these data indicate that CRHR2 triggers the PKA signalling pathway and increases p-HSL and p-peri expression under hypoxic conditions.
Discussion
Our study revealed that continuous exposure to hypoxia for up to 10 d, equivalent to an altitude of 5000 m, initially caused significant weight loss and decreased food intake. Although food intake was normalised by Day 5 of the trial, the body weight remained much lower in hypoxic rats than in normoxic rats throughout the trial. We also found that the levels of UCP-1 in BAT also increased by hypoxia, indicating that hypoxia enhances thermogenesis and energy expenditure. These data suggest that hypoxic rats established new homeostatic equilibrium, which was characterised by a hypermetabolic state.
In the present study, we found that exposure to hypoxia resulted in a significant reduction in adipocyte volume, accompanied by increased plasma levels of glycerol and FFA. These data suggested that hypoxia exposure markedly enhanced lipolysis in WAT. Consistent with our finding, Hashimoto et al. (2013) reported prominent reductions in LD size and triglyceride content (by 50%) in 3T3-L1 adipocytes cultured under 5% O 2 for 1 week compared with cells cultured in normoxic conditions. Given that the adipocyte volume is determined by intracellular triglyceride content, we hypothesised that the reduction in adipocyte volume was due to increased triglyceride mobilisation. Hormone-sensitive lipase (HSL) is the predominant lipase effector of lipolysis in adipocytes, which is mediated by protein kinase A (PKA)-dependent phosphorylation of perilipin (Sztalryd et al., 2003) . It is well established that perilipin phosphorylation is essential for the translocation of HSL from the cytoplasm to the LD surface to increase lipolytic activity (Miyoshi et al., 2006) . As predicted, we found that hypoxia exposure significantly increased phosphorylation of HSL and perilipin through PKA, suggesting that cAMP-PKA pathway may play vital role in mediating the lipolytic effect of hypoxia.
Emerging evidence proved that hypoxia could inhibit the differentiation process of preadipocytes (Kim et al., 2005; Zhou et al., 2005) and lipogenic metabolism of triglyceride in adipocyte (Gentil et al., 2006) . The PPAR-c is a highly expressed transcription factor in WAT, where it is a master regulator of lipogenesis as well as a potent modulator of whole-body lipid metabolism (Evans Tontonoz and Spiegelman, 2008) . It has been shown that the levels of PPAR-c are influenced by oxygen tension and hypoxia condition attenuates adipocyte differentiation by inhibition of PPAR-c expression (Kim et al., 2005) . Nishiyama et al. (2012) found that HIF-1a knockout mice showed significant accumulation of fat in the liver, and liver cells significantly increased SREBP-1c and its downstream target gene expression levels with the increase of liver steatosis. In the current study, hypoxia exposure significantly decreased expression levels of PPAR-c, SREBP1c and FAS, suggesting that impaired lipogenesis could contribute to WAT loss under hypoxia exposure. Taken together, these results suggest that the loss of WAT under continuous exposure to hypoxia was due to the activation of lipolysis and the suppression of lipogenesis. In addition, enhanced thermogenesis and energy expenditure and transient appetite loss at day 1-5 might also contribute to the reduction in fat mass.
We also found that the mRNA expression levels of b-oxidation related genes in WAT are upregulated by hypoxia. In line with our work, another simulated high altitude hypoxia study observed that the acute exposure of rats to hypoxia led to a significant increase in the expressions of CPT-1 and PPAR-a, indicating increased hepatic FFA oxidation under hypoxia (Ni et al. 2014) . Further studies are needed to investigate the precise mechanisms by which hypoxia induces these changes.
In this study, we found that hypoxia significantly unregulated the expression levels of Ucn2 and Ucn3 in WAT. HIF-1 is one of Fig. 6 . Hypoxia increased the expression levels of Ucn2, Ucn3 and CRHR2 in WAT. The expression levels of Ucn2 and CRHR2 in WAT from rats exposed to hypoxia for 1, 2, 5, or 10 d are shown. Data are shown as the mean ± SE of at least two independent real-time PCR experiments or western blot of rats in each experimental group (n = 6 per group), Ucn2, and Ucn3 mRNA expression levels in WAT, (E-G) CRHR2, Ucn2, and HIF-1a protein expression levels in WAT (top, western blot; bottom, CRHR2, Ucn2, and HIF-1a protein relative to actin and normalised to the normoxic group).
the most important transcription factor in mediating the primary transcriptional responses to hypoxic stress by binding hypoxia response elements (HREs) of targeted genes (Weidemann and Johnson, 2008) . Buhler et al. (2009) reported that hypoxia could induce human Ucn2 expression via specific HRE in the 3 0 flanking region of the Ucn2 gene that interact with the transcription factor HIF-1a. Imperatore et al. (2010) found that placental Ucn2 and Ucn3 expression was sensitive to O 2 tensions and mediated by HIF-1a. Herein, we speculate that increased HIF-1a expression might be involved in the upregulation of Ucn2 and Ucn3 in WAT.
CRHR2 is coupled to Gsa (Dautzenberg and Hauger, 2002) , which activates adenylyl cyclase and cAMP formation. In turn, cAMP activates PKA, which directly phosphorylates multiple proteins to induce a variety of effects. Furthermore, the cAMP-PKA signalling pathway plays prominent roles in mediating the physiological effects of CRHR2-related peptides in most target tissues (Grammatopoulos., 2012) . HSL is the predominant lipase in adipocytes, and its activity is dependent on its phosphorylation via PKA. We found that hypoxia exposure significantly increased phosphorylation of HSL and perilipin under hypoxia. Meanwhile, hypoxia also induced significant upregulation of Ucn2 and Ucn3 in WAT, indicating activated CRHR2-PKA pathway under hypoxia. Furthermore, pretreatment with a CRHR2 antagonist, astressin 2B significantly attenuated hypoxia induced WAT loss and increased p-HSL and p-Perilipin levels. These data suggested that p-HSL and p-Perilipin expression in WAT was dependent on CRHR2-cAMP-PKA activation in hypoxic conditions. Our results suggested that endogenous Ucn2/Ucn3-CRHR2 has a specific autocrine/paracrine function that involved activation of the cAMP-PKA-HSL/perilipin pathway (Fig. 8) . However, astressin 2B treatment failed to reverse hypoxia induced inhibition of PPAR-c, indicating that CRHR2 was not involved in the regulation of lipogenic metabolism of triglyceride.
The lipogenic and lipolysis regulation of WAT is a complex process involved with numerous factors. Hypoxic challenge may also activate the sympathetic adrenal medullary system, induced changes in the release of inflammatory cytokine and adipokine. These factors might participate in the WAT loss mediated hypoxia exposure (Green et al., 2004; Magnoni et al. 2008) . Further study are needed to explore the effect of these factors in hypoxia induce lipid metabolism.
In conclusion, continuous exposure to hypoxia significantly increased lipolysis metabolism, at least in part by activating the local Ucn2/3-CRHR2-cAMP-PKA pathway in WAT in autocrine/ paracrine manner. These findings provide the novel understanding of local CRHR2 signaling pathway being involved in WAT loss and lipid metabolism under hypoxia. 
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